Andrew Bryant

9.0k total citations · 3 hit papers
110 papers, 5.2k citations indexed

About

Andrew Bryant is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Andrew Bryant has authored 110 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Reproductive Medicine, 45 papers in Obstetrics and Gynecology and 31 papers in Surgery. Recurrent topics in Andrew Bryant's work include Ovarian cancer diagnosis and treatment (44 papers), Endometrial and Cervical Cancer Treatments (43 papers) and Cervical Cancer and HPV Research (24 papers). Andrew Bryant is often cited by papers focused on Ovarian cancer diagnosis and treatment (44 papers), Endometrial and Cervical Cancer Treatments (43 papers) and Cervical Cancer and HPV Research (24 papers). Andrew Bryant collaborates with scholars based in United Kingdom, United States and Malaysia. Andrew Bryant's co-authors include Khadra Galaal, Pierre PL Martin-Hirsch, Jo Morrison, Heather O Dickinson, Alberto Lopes, Raj Naik, Theresa A Lawrie, Evangelos Paraskevaidis, Ahmed Elattar and Katie E Webster and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Andrew Bryant

107 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytology versus HPV testing for cervical cancer screening in the general population

2017 341 citations Andrew Bryant, Holger J. Schünemann et al. Cochrane Database of Systematic Reviews profile →
Lymphadenectomy for the management of endometrial cancer

2017 234 citations Jonathan Frost, Katie E Webster et al. Cochrane Database of Systematic Reviews profile →
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines

2021 143 citations Andrew Bryant, Theresa A Lawrie et al. American Journal of Therapeutics profile →

Peers

Countries citing papers authored by Andrew Bryant

Since Specialization

Citations

This map shows the geographic impact of Andrew Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bryant more than expected).

Fields of papers citing papers by Andrew Bryant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bryant. The network helps show where Andrew Bryant may publish in the future.

Co-authorship network of co-authors of Andrew Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bryant. A scholar is included among the top collaborators of Andrew Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bryant. Andrew Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cost-effectiveness of lifelong eculizumab versus disease monitoring of aHUS 2025 ·Nephrology Dialysis Transplantation ·(unknown), Luke Vale, Yemi Oluboyede, (unknown), Andrew Bryant, Thomas Chadwick, (unknown), Sally Johnson, David Kavanagh, (unknown), Jan Lecouturier, (unknown), Edwin Wong, (unknown), Neil Sheerin	0
2	Preventing Cardiomyopathy in Duchenne Muscular Dystrophy: Long‐Term Follow‐Up of Patients in the Randomised, Placebo‐Controlled Drug‐Trial of Perindopril and Bisoprolol 2025 ·European Journal of Neurology ·John Bourke, Andrew Bryant, (unknown), (unknown), Stefan Spinty, Rosaline C. M. Quinlivan, (unknown), Thomas Chadwick, Francesco Muntoni, Michela Guglieri, (unknown)	0
3	Current practices in studies applying the target trial emulation framework: a protocol for a systematic review 2023 ·BMJ Open ·Theophile Bigirumurame, Shaun Hiu, M. Dawn Teare, James Wason, Andrew Bryant, Matthew Breckons	2
4	Improving the uptake of cervical screening in pregnant and recently postnatal women: a quality improvement project 2022 ·BMJ Open Quality ·(unknown), (unknown), Ellen Nelissen, Rob Bethune, Richard E. Blackwell, Andrew Bryant, Jo Morrison	5
5	Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study 2022 ·BMJ Open ·(unknown), (unknown), Andrew Bryant, Sonya Carnell, Thomas Chadwick, Sally Johnson, David Kavanagh, Jan Lecouturier, Michal Malina, Eoin Moloney, Yemi Oluboyede, (unknown), Edwin Wong, (unknown), Neil Sheerin	5
6	Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis 2022 ·BMJ Open ·Andrew Bryant, Michael J. Grayling, Shaun Hiu, Ketankumar Gajjar, (unknown), Ahmed Elattar, Luke Vale, Dawn Craig, Raj Naik	1
7	Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines breakdown → 2021 ·American Journal of Therapeutics ·Andrew Bryant, Theresa A Lawrie, Therese Dowswell, Edmund J. Fordham, Scott A. Mitchell, Sarah Hill, Tony Tham	143
8	Preventing Cardiomyopathy in DMD 2020 ·Neurology Clinical Practice ·John Bourke, Gillian Watson, Stefan Spinty, Andrew Bryant, Helen Roper, Thomas Chadwick, Ruth Wood, Elaine McColl, Kate Bushby, Francesco Muntoni, Michela Guglieri, (unknown)	10
9	Does domiciliary welfare rights advice improve health-related quality of life in independent-living, socio-economically disadvantaged people aged ≥60 years? Randomised controlled trial, economic and process evaluations in the North East of England 2019 ·PLoS ONE ·Denise Howel, Suzanne Moffatt, Catherine Haighton, Andrew Bryant, Frauke Becker, Mel Steer, Sarah Lawson, Terry Aspray, Eugene Milne, Luke Vale, Elaine McColl, Martin White	11
10	Rituximab Is Ineffective for Treatment of Fatigue in Primary Biliary Cholangitis: A Phase 2 Randomized Controlled Trial 2018 ·Hepatology ·Amardeep Khanna, Laura Jopson, Denise Howel, Andrew Bryant, Andrew M. Blamire, Julia L. Newton, D. I. Jones	51
11	Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial 2018 ·SHILAP Revista de lepidopterología ·Amardeep Khanna, Laura Jopson, Denise Howel, Andrew Bryant, Andrew M. Blamire, Julia L. Newton, Jennifer Wilkinson, (unknown), (unknown), Renae J. Stefanetti, Sophie Cassidy, David Houghton, David Jones	6
12	Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study 2018 ·BMJ Open ·John Bourke, Gillian Watson, Francesco Muntoni, Stefan Spinty, Helen Roper, Michela Guglieri, Chris Speed, Elaine McColl, Ashish Chikermane, Sandeep Jayawant, Satish Adwani, Tracey Willis, Jennifer Wilkinson, Andrew Bryant, Thomas Chadwick, Ruth Wood, Kate Bushby	17
13	Early Supported Discharge/Hospital At Home For Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Review and Meta-Analysis 2016 ·COPD Journal of Chronic Obstructive Pulmonary Disease ·Carlos Echevarria, (unknown), (unknown), Andrew Bryant, Sally Corbett, John Steer, Stephen C Bourke	38
14	A mixed methods study to assess the feasibility of a randomised controlled trial of invasive urodynamic testing versus clinical assessment and non-invasive tests prior to surgery for stress urinary incontinence in women: the INVESTIGATE-I study 2015 ·Trials ·(unknown), Paul Hilton, Natalie Armstrong, Catherine Brennand, Denise Howel, Jing Shen, Andrew Bryant, Douglas G. Tincello, Malcolm G Lucas, Brian S Buckley, Christopher R. Chapple, Tara Homer, Luke Vale, Elaine McColl	7
15	Lymphadenectomy for the management of endometrial cancer 2015 ·Cochrane Database of Systematic Reviews ·Jonathan Frost, Katie E Webster, Andrew Bryant, Jo Morrison	78
16	Parenteral anticoagulation in ambulatory patients with cancer 2014 ·Cochrane Database of Systematic Reviews ·Elie A. Akl, Lara A Kahale, Rami A. Ballout, Maddalena Barba, Victor E D Yosuico, Frederiek F van Doormaal, Saskia Middeldorp, Andrew Bryant, Holger J. Schünemann	53
17	Optimal primary surgical treatment for advanced epithelial ovarian cancer 2011 ·Cochrane Database of Systematic Reviews ·Ahmed Elattar, Andrew Bryant, Brett Winter‐Roach, Mohamed Hatem, Raj Naik	287
18	Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation 2011 ·Cochrane Database of Systematic Reviews ·Elie A. Akl, Sameer Gunukula, Maddalena Barba, Victor E D Yosuico, Frederiek F van Doormaal, Saskia Kuipers, Saskia Middeldorp, Heather O Dickinson, Andrew Bryant, Holger J. Schünemann	28
19	Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer 2009 ·Cochrane Database of Systematic Reviews ·Linda Rogers, Shing Shun N Siu, David Luesley, Andrew Bryant, Heather O Dickinson	14
20	A model for the electrical and magnetic properties of amorphous carbons based on fullerene-type structures† 1995 ·International Journal of Electronics ·Lawrence J. Dunne, (unknown), (unknown), Andrew Bryant	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact